Clinical Trials Directory

Trials / Unknown

UnknownNCT03414580

Analysis of Volatile Organic Compounds in the Exhaled Air in Inflammatory Bowel Disease

Analysis of Volatile Organic Compounds in Exhaled Air in Patients With Inflammatory Bowel Disease Patients and Healthy Control

Status
Unknown
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Keimyung University Dongsan Medical Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

The availability of noninvasive biomarkers for diagnosis and stratification of inflammatory bowel disease (IBD) courses is lacking. Thus, the aim of this study is to evaluated the accuracy of exhaled breath volatile metabolite analysis on diagnosis and stratification of patients with inflammatory bowel disease.

Detailed description

Background: The diagnosis and differentiation of inflammatory bowel diseases (IBD) is challenging due to the absence of a gold standard diagnostic modality for confirmation. Exhaled breath volatile metabolite analysis focusing on diagnosis and differentiation of IBD is a promising approach. Thus, the aim of this study is to evaluated the accuracy of exhaled breath volatile metabolite analysis for patients with inflammatory bowel disease. Method: A single center, prospective study of diagnostic testing will be conducted, recruiting crohn's disease (CD), ulcerative colitis (UC), and healthy controls (HC). The exhaled breath volatile metabolite will be analyzed using gas chromatography/mass spectrometry (GC-MS). The informations of patient's disease location, disease activity, laboratory parameters and current medications will be collected to determine the feasibility of exhaled breath volatile metabolite analysis.

Conditions

Interventions

TypeNameDescription
PROCEDUREBreath sampling for volatile organic compoundsAcquisition of exhaled breath sample in exhaled air to be analysed by gas chromatography-mass spectrometry

Timeline

Start date
2018-02-20
Primary completion
2021-06-01
Completion
2021-06-01
First posted
2018-01-30
Last updated
2020-09-03

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03414580. Inclusion in this directory is not an endorsement.